Table 1.

Clinicopathologic characteristics of lung cancer patients.

Characteristics	Cases (%)#	HOXC10 mRNA expression (Mean ± SD)	p-value
Total	63	4.219 ± 2.134
Gender			0.6330
Male	41 (65.1)	4.124 ± 2.168
Female	22 (34.9)	4.396 ± 2.108
Age (years)			0.3293
≥60	43 (68.3)	4.058 ± 1.969
< 60	20 (31.7)	4.654 ± 2.544
Tumor size (longest dimension) ≤ 5 cm	49 (77.7)	4.188 ± 2.094	0.8312
>5 cm	14 (22.3)	4.327 ± 2.347
Smoking status			0.0031*
Current or former smoker	45 (71.4)	4.710 ± 2.148
Non-smoker	18 (28.6)	2.990 ± 1.559
TNM stage			< 0.0001*
I-II	25 (39.7)	2.955 ± 1.196
III-IV	38 (60.3)	5.050 ± 2.217
Lymph node Metastasis			< 0.0001*
N0	40 (63.5)	2.975 ± 1.458
N1-3	23 (36.5)	4.934 ± 2.146
Distal metastasis			< 0.0001*
M0	46 (73.0)	3.605 ± 1.407
M1	17 (27.0)	5.879 ± 2.840

TNM, tumor-node-metastasis; SD, Standard deviation.

^*p < 0.05 was considered statistically significant.

^#Three patients were excluded in survival analysis as information missed during follow-up.